TrianglePUBLICATIONS · 29808014
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Br J Cancer
- Publication date
- 2018 Jul
- First author
- Chau I
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Chau I
- type
- Author
- name
- Park JO
- type
- Author
- name
- Ryoo BY
- type
- Author
- name
- Yen CJ
- type
- Author
- name
- Poon R
- type
- Author
- name
- Pastorelli D
- type
- Author
- name
- Blanc JF
- type
- Author
- name
- Kudo M
- type
- Author
- name
- Pfiffer T
- type
- Author
- name
- Hatano E
- type
- Author
- name
- Chung HC
- type
- Author
- name
- Kopeckova K
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Chau I
- type
- Author
- name
- Park JO
- type
- Author
- name
- Ryoo BY
- type
- Author
- name
- Yen CJ
- type
- Author
- name
- Poon R
- type
- Author
- name
- Pastorelli D
- type
- Author
- name
- Blanc JF
- type
- Author
- name
- Kudo M
- type
- Author
- name
- Pfiffer T
- type
- Author
- name
- Hatano E
- type
- Author
- name
- Chung HC
- type
- Author
- name
- Kopeckova K
- type
- Author
- bibliography ids
- nci-bib-d640e9dc67d199e3087f4644
- book metadata
- content sha256
- 46c208b625b52a4f89e8fbc6660db84ca933ad6e869ccd95c117b0146fcd4d9a
- document type
- citation
- dois
- 10.1038/s41416-018-0103-0
- electronic publication date
- display
- 2018 May 29
- precision
- day
- year
- 2018
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:29808014
- immutable id
- pubmed:29808014@46c208b625b52a4f89e8fbc6660db84ca933ad6e869ccd95c117b0146fcd4d9a
- journal
- abbreviation
- Br J Cancer
- issn electronic
- 1532-1827
- issn print
- 0007-0920
- issue
- 1
- name
- British journal of cancer
- nlm unique id
- 0370635
- pages
- 19-26
- volume
- 119
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 29808014
- provenance
- batch id
- c4c0356d060413f719c2
- provider
- NCBI PubMed ESummary
- record sha256
- 0a05760a431d5a811fa4a22333f954ca8f69a4aa29f36c010ade73674e078356
- response sha256
- adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
- retrieved at
- 2026-09-09T23:47:33.674758+00:00
- publication date
- display
- 2018 Jul
- precision
- month
- year
- 2018
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.
Preserved source evidence · Not medical advice